[(3R,9S,12S,15S,18S,24S,27S,30S)-9-Benzyl-24-(3-guanidino-propyl)-15-isobutyl-12,27-dimethyl-2,8,11,14,17,20,23,26,29-nonaoxo-1,7,10,13,16,19,22,25,28-nonaaza-tricyclo[28.3.0.0(3,7)]tritriacont-18-yl]-acetic acid

ID: ALA4575627

Chembl Id: CHEMBL4575627

PubChem CID: 155563936

Max Phase: Preclinical

Molecular Formula: C43H64N12O11

Molecular Weight: 925.06

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C)NC1=O

Standard InChI:  InChI=1S/C43H64N12O11/c1-23(2)19-28-38(62)48-24(3)36(60)53-30(20-26-11-6-5-7-12-26)41(65)55-18-10-15-32(55)42(66)54-17-9-14-31(54)40(64)49-25(4)35(59)51-27(13-8-16-46-43(44)45)37(61)47-22-33(56)50-29(21-34(57)58)39(63)52-28/h5-7,11-12,23-25,27-32H,8-10,13-22H2,1-4H3,(H,47,61)(H,48,62)(H,49,64)(H,50,56)(H,51,59)(H,52,63)(H,53,60)(H,57,58)(H4,44,45,46)/t24-,25-,27-,28-,29-,30-,31-,32+/m0/s1

Standard InChI Key:  ZDSIXCUNSXFSMQ-LBCAYJJCSA-N

Alternative Forms

  1. Parent:

    ALA4575627

    ---

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-5/beta-1 (686 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-8 (181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 925.06Molecular Weight (Monoisotopic): 924.4818AlogP: -2.93#Rotatable Bonds: 10
Polar Surface Area: 343.52Molecular Species: ZWITTERIONHBA: 11HBD: 11
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.06CX Basic pKa: 11.35CX LogP: -5.14CX LogD: -5.14
Aromatic Rings: 1Heavy Atoms: 66QED Weighted: 0.06Np Likeness Score: 0.82

References

1. Reichart F, Maltsev OV, Kapp TG, Räder AFB, Weinmüller M, Marelli UK, Notni J, Wurzer A, Beck R, Wester HJ, Steiger K, Di Maro S, Di Leva FS, Marinelli L, Nieberler M, Reuning U, Schwaiger M, Kessler H..  (2019)  Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide.,  62  (4): [PMID:30657681] [10.1021/acs.jmedchem.8b01588]

Source